Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: Role of pro-inflammatory cytokines

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 4, 2006, Pages

  Krizanac Bengez, Ljiljana ^a   Hossain, Mohammed ^a   Fazio, Vince ^a   Mayberg, Marc ^b   Janigro, Damir ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

Author keywords

Inflammation; Matrix metalloproteinases; Shear stress

Indexed keywords

CYTOKINE; GELATINASE A; GELATINASE B; INTERLEUKIN 6 ANTIBODY; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; RAT; REPERFUSION; ZYMOGRAPHY;

ANIMALS; BLOOD PHYSIOLOGY; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION MEDIATORS; INJECTIONS; LEUKOCYTES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; RATS; RATS, SPRAGUE-DAWLEY; STRESS, MECHANICAL; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33749341863     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00516.2005     Document Type: Article

References (52)

1. Alvarez-Sabin J, Delgado P, Abilleira S, Molina CA, Arenillas J, Ribo M, Santamarina E, Quintana M, Monasterio J, and Montaner J. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke 35: 1316-1322, 2004.
2. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ, and Murphy G. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435: 39-44, 1998.
3. Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, and Banda MJ. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322-2329, 1990.
4. Arisaka T, Mitsumata M, Kawasumi M, Tohjima T, Hirose S, and Yoshida Y. Effects of shear stress on glycosaminoglycan synthesis in vascular endothelial cells. Ann NY Acad Sci 748: 543-554, 1995.
5. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, and Lo EH. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20: 1681-1689, 2000.
6. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, and Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21: 7724-7732, 2001.
7. Baker AH, Zaltsman AB, George SJ, and Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 101: 1478-1487, 1998.
8. Brew K, Dinakarpandian D, and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: 267-283, 2000.
9. Bugno M, Witek B, Bereta J, Bereta M, Edwards DR, and Kordula T. Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett 448: 9-14, 1999.
10. Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, Adams SE, and Gearing AJ. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 72: 155-161, 1997.
11. Chang DI, Hosomi N, Lucero J, Heo JH, Abumiya T, Mazar AP, and del Zoppo GJ. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia. J Cereb Blood Flow Metab 23: 1408-1419, 2003.
12. Davies PF, Dewey CF Jr, Bussolari SR, Gordon EJ, and Gimbrone MA, Jr. Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells. J Clin Invest 73: 1121-1129, 1984.
13. Del Zoppo GJ and Hallenbeck JM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 98: 73-81, 2000.
14. Del Zoppo GJ, von Kummer R, and Hamann GF. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry 65: 1-9, 1998.
15. Desai S, McAllister MS, Mayberg MR, and Janigro D. Mechanisms of endothelial survival under shear stress. In: Blood-Brain Barrier Delivery and Brain Pathology, edited by Kobiler D, Lustig HS, and Shapira S. Amsterdam, The Netherlands: Kluwer Academic, 2001, p. 63-70.
16. Goetzl EJ, Banda MJ, and Leppert D. Matrix metalloproteinases in immunity. J Immunol 156: 1-4, 1996.
17. Gomez DE, Alonso DF, Yoshiji H, and Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74: 111-122, 1997.
18. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, and van Hinsbergh VW. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 296: 803-809, 1993.
19. Hummel V, Kallmann BA, Wagner S, Fuller T, Bayas A, Tonn JC, Benveniste EN, Toyka KV, and Rieckmann P. Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J Neuropathol Exp Neurol 60: 320-327, 2001.
20. Ito A, Mukaiyama A, Itoh Y, Nagase H, Thogersen IB, Enghild JJ, Sasaguri Y, and Mori Y. Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem 271: 14657-14660, 1996.
21. Johnatty RN, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam DW, Stephenson TJ, and Rees RC. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 158: 2327-2333, 1997.
22. Justicia C, Panes J, Sole S, Cervera A, Deulofeu R, Chamorro A, and Planas AM. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 23: 1430-1440, 2003.
23. Kouwenhoven M, Carlstrom C, Ozenci V, and Link H. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke. J Clin Immunol 21: 365-375, 2001.
24. Kouwenhoven M, Ozenci V, Gomes A, Yarilin D, Giedraitis V, Press R, and Link H. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J Autoimmun 16: 463-470, 2001.
25. Krizanac-Bengez L, Kapural M, Parkinson F, Cucullo L, Hossain M, Mayberg MR, and Janigro D. Effects of transient loss of shear stress on blood-brain barrier endothelium: role of nitric oxide and IL-6. Brain Res 977: 239-246, 2003.
26. Krizanac-Bengez L, Mayberg MR, Cunningham E, Hossain M, Ponnampalam S, Parkinson FE, and Janigro D. Loss of shear stress induces leukocyte-mediated cytokine release and blood-brain barrier failure in dynamic in vitro blood-brain barrier model. J Cell Physiol 206: 68-77, 2006.
27. Leppert D, Waubant E, Galardy R, Bunnett NW, and Hauser SL. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154: 4379-4389, 1995.
28. Mach F, Schonbeck U, Fabunmi RP, Murphy C, Atkinson E, Bonnefoy JY, Graber P, and Libby P. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. Am J Pathol 154: 229-238, 1999.
29. Malek AM, Alper SL, and Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 282: 2035-2042, 1999.
30. Mannello F and Gazzanelli G. Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 6: 479-482, 2001.
31. Mark KS and Davis TP. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 282: H1485-H1494, 2002.
32. McKhann GM, D'Ambrosio R, and Janigro D. Heterogeneity of astrocyte resting membrane potentials revealed by whole cell and gramicidin-perforated patch recordings from cultured neocortical and hippocampal slice astrocytes. J Neurosci 17: 6850-6863, 1997.
33. Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, and Rogers JH. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res Mol Brain Res 100: 103-117, 2002.
34. Nagase H, Meng Q, Malinovskii V, Huang W, Chung L, Bode W, Maskos K, and Brew K. Engineering of selective TIMPs. Ann NY Acad Sci 878: 1-11, 1999.
35. Pardridge WM. Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev 63: 1481-1535, 1983.
36. Romanic AM and Madri JA. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 4: 145-156, 1994.
37. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 39: 279-291, 2002.
38. Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, and Gearing A. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893: 104-112, 2001.
39. Rosenberg GA, Estrada EY, and Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29: 2189-2195, 1998.
40. Rosenberg GA, Kornfeld M, Estrada E, Kelley RO, Liotta LA, and Stetler-Stevenson WG. TIMP-2 reduces proteolytic opening of bloodbrain barrier by type IV collagenase. Brain Res 576: 203-207, 1992.
41. Stanness KA, Guatteo E, and Janigro D. A dynamic model of the blood-brain barrier "in vitro". Neurotoxicology 17: 481-496, 1996.
42. Stanness KA, Westrum LE, Fornaciari E, Mascagni P, Nelson JA, Stenglein SG, Myers T, and Janigro D. Morphological and functional characterization of an in vitro blood-brain barrier model. Brain Res 771: 329-342, 1997.
43. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, and Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338, 1995.
44. Suryadevara R, Holter S, Borgmann K, Persidsky R, Labenz-Zink C, Persidsky Y, Gendelman HE, Wu L, and Ghorpade A. Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia 44: 47-56, 2003.
45. Tan HK, Heywood D, Ralph GS, Bienemann A, Baker AH, and Uney JB. Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol Cell Neurosci 22: 98-106, 2003.
46. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, and Lo EH. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36: 1954-1959, 2005.
47. Utepbergenov DI, Mertsch K, Sporbert A, Tenz K, Paul M, Haseloff RF, and Blasig IE. Nitric oxide protects blood-brain barrier in vitro from hypoxia/reoxygenation-mediated injury. FEBS Lett 424: 197-201, 1998.
48. Wei Z, Costa K, Al-Mehdi AB, Dodia C, Muzykantov VR, and Fisher AB. Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ Res 85: 682-689, 1999.
49. Wood A, Wing MG, Benham CD, and Compston DA. Specific induction of intracellular calcium oscillations by complement membrane attack on oligodendroglia. J Neurosci 13: 3319-3332, 1993.
50. Yong VW, Power C, Forsyth P, and Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2: 502-511, 2001.
51. Yoshida Y, Okano M, Wang S, Kobayashi M, Kawasumi M, Hagiwara H, and Mitsumata M. Hemodynamic-force-induced difference of interendothelial junctional complexes. Ann NY Acad Sci 748: 104-120, 1995.
52. Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, Nagase H, Kashiwagi M, Soloway PD, DeClerck YA, and Fridman R. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 regulates pro-MMP-2 activation. J Biol Chem 279: 8592-8601, 2004.